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Binding of Gβγ subunits to cRaf1 downregulates G-protein-
coupled receptor signalling
Joseph R. Slupsky*†‡, Ursula Quitterer§‡, Christoph K. Weber*‡,
Peter Gierschik¶, Martin J. Lohse§ and Ulf R. Rapp*
Receptors of the seven transmembrane domain family
are coupled to heterotrimeric G proteins [1]. Binding of
ligand to these receptors induces dissociation of the
heterotrimeric complex into free GTP–Gα and
Gβγ subunits, which then interact with their respective
effector molecules to stimulate specific cellular
responses. In some cases, these cellular responses
involve mitogenic signalling [2]. The mitogen-activated
protein (MAP) kinase cascade is initiated by the protein
kinase cRaf1 and links growth factor receptor signalling
to cell growth and differentiation [3]. The main activator
of cRaf1 is the small GTP-binding protein Ras [4], and the
binding of cRaf1 to GTP–Ras translocates cRaf1 to the
plasma membrane, where it is activated [5]. It has been
reported that cRaf1 associates directly with the β subunit
of heterotrimeric G proteins in vitro, and with the
βγ subunit complex in vivo [6], but the role of this
association is not yet understood. Here, we show that
cRaf1 associates with Gβ1γ2, and that this association in
mammalian cells is significantly enhanced when active
p21Ras is present or when cRaf1 is otherwise targeted to
the membrane. Association with Gβ1γ2 has no effect on
the kinase activity of cRaf1, but cRaf1 can affect
Gβγ-mediated signalling events. Thus, membrane-
localised cRaf1 inhibits G-protein-coupled receptor
(GPCR)-stimulated activation of phospholipase Cβ (PLCβ)
by sequestration of Gβγ subunits, an effect also observed
with endogenous levels of cRaf1. Our data suggest that
cRaf1 may be an important regulator of signalling by Gβγ,
particularly in those GPCR systems that stimulate the
MAP kinase cascade through the activation of p21Ras.
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Results and discussion
cRaf1 associates with Gβ1γ2
We found that cRaf1 and Gβγ reciprocally co-immunopre-
cipitated when they were co-expressed in Sf9 insect cells
(data not shown), confirming previously published data [6].
Similar results were observed when cRaf1 and Gβ1γ2 were
cotransfected into HEK293 mammalian cells; the degree of
this association was significantly enhanced, however, by
the presence of an activated mutant of Ha-Ras, Ha-
Ras(G12V) with amino acids in the single-letter code
(Figure 1a). The kinase activity of cRaf1 was not important
for its association with Gβγ, because a kinase-dead mutant
of cRaf1, cRaf1(K375W), also associated with Gβ1γ2 in the
presence of Ha-Ras(G12V). In contrast, a non-Ras binding
mutant, cRaf1(R89L), did not associate with Gβ1γ2, either
in the presence or the absence of Ha-Ras(G12V). Because
the latter mutant of cRaf1 does not associate with the
plasma membrane under the conditions used [7], our data
suggest that either Ras binding or membrane translocation
is necessary for cRaf1–Gβ1γ2 complex formation.
We next found that plasma-membrane-targeted cRaf1
(cRaf1-CX) associated with Gβγ (Figure 1b). This associa-
tion was independent of Ras or of cRaf1 kinase activity
because a non-Ras-binding, kinase-dead mutant cRaf1,
cRaf1-CX(R89L,K375W), also coprecipitated Gβ1γ2.
Thus, membrane translocation is necessary for the forma-
tion of the cRaf1–Gβγ complex. This observation is sup-
ported by the fact that the cRaf1–Gβγ complex was isolated
mainly from the membrane (P100) fraction of the trans-
fected cells (data not shown). Plasma-membrane-targeted
cRaf1 binds lipids [8] and is postulated to change struc-
turally when activated [3,7]. Moreover, in vitro binding data
show a high dissociation constant (Kd = 163 ± 36 nM) for
the complex [6], suggesting that membrane targeting of
cRaf1 leads to a localised increase in concentration of the
components, resulting in the formation of the complex.
Whether or not cRaf1 was at the membrane, association
with Gβ1γ2 neither enhanced nor inhibited kinase activity
(see Supplementary material, and data not shown), indicat-
ing that Gβγ is not an activator of cRaf1.
cRaf1 inhibits Gβγ-induced activation of PLCβ
These results suggest that binding of cRaf1 may have
consequences for Gβγ-mediated signalling. PLCβ2 is
activated by Gβγ to hydrolyse phosphatidyl inositol bis-
phosphate to inositol trisphosphate and diacylglycerol [9].
Co-expression of cRaf1 and Ha-Ras(G12V) reduced
Gβ1γ2-mediated PLCβ2 activation by approximately
50%, whereas expression of either of these components
alone or co-expression of cRaf1(R89L) and Ha-
Ras(G12V) had no effect (Figure 2a). A similar reduction
in Gβ1γ2-mediated activation of PLCβ2 was also induced
by expression of cRaf1-CX, and this was independent of
the kinase activity of cRaf1 (Figure 2b). Similar data were
also obtained with COS-1 cells (data not shown).
The B2 receptor for the hormone bradykinin activates the
MAP kinase cascade in a Ras-dependent manner [10].
Figure 3a shows that bradykinin-induced PLCβ activation
in cells transfected with the B2 receptor was inhibited by
the co-expression of cRaf1 (25–30% in COS-1 and
30–40% in HEK293 cells) or cRaf1-CX, but not
cRaf1(R89L). In the same type of experiment, bradykinin
stimulated kinase activity of the wild-type but not the
R89L form of cRaf1 (Figure 3b), confirming that the B2
receptor mediates Ras-induced activation of cRaf1. The
B2 receptor is coupled mainly to the Gαq and Gαi pro-
teins [11] and, in our system, pertussis toxin treatment of
cells (which inhibits G proteins) inhibited bradykinin-
induced inositol phosphate production by 25–30% (data
not shown). Moreover, PLCs of the β isozyme subfamily
can be activated by both Gαq and Gβγ [12], but cRaf1-
CX(R89L,K375W) did not affect PLCβ1 activation by
Gαq or Gα11 (Figure 2c). Thus, our data suggest that
972 Current Biology, Vol 9 No 17
Figure 1
Association of cRaf1 with Gβ1γ2 in HEK293
cells. HEK293 cells were transfected with
plasmids expressing haemagglutinin (HA)-
tagged wild-type (wt) and mutant cRaf1, no
protein (pcDNA), Gβ1γ2 and/or Ras(G12V)
as indicated, using calcium phosphate
precipitation. The transfected cells were lysed
with NP40 lysis buffer (150 mM NaCl, 25 mM
Na4P2O7, 50 mM Na-glycerophosphate,
2 mM EDTA, 2 mM EGTA, 25 mM Tris pH 8.0,
10% glycerol, 0.5% NP40) containing
10 µg/ml leupeptin, 10 µg/ml aprotinin and
1 mM PMSF as described [20]. The prepared
lysates were then immunoprecipitated (2 h,
4°C) with the specific antibodies indicated,
which had been pre-adsorbed to protein-
A–Sepharose. The immunoprecipitating
proteins (IP) were then separated by
SDS–PAGE and analysed by western blotting
for co-immunoprecipitating proteins.
(a) Western blot analysis of proteins co-
immunoprecipitating with HA–cRaf1.
(b) Western blot analysis of proteins co-
immunoprecipitating with HA–cRaf1-CX. The
western blot analysis also showed that anti-
Gβ antibodies coprecipitated HA–cRaf1 and
HA–cRaf1-CX (data not shown). The data are
representative of three separate experiments.
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Figure 2
Effect of membrane targeting of cRaf1 on
Gβ1γ2-mediated stimulation of PLCβ2.
HEK293 cells were cotransfected with the
indicated cDNAs as in Figure 1 together with
cDNA for PLCβ2 and the levels of basal
inositol phosphates compared to mock-
transfected control cells (0%) and Gβ1γ2-
transfected cells (100%) was determined
[21]. The effect of cRaf1 on Gβ1γ2-stimulated
PLCβ2 activity (100%) was determined on
cells cotransfected with cDNAs encoding
(a) cRaf1 or (b) membrane-targeted cRaf1,
cRaf1-CX. Similar data were obtained using
COS-1 cells (data not shown). The increases
in basal inositol phosphates of HEK293 cells
were 140 ± 15 cpm per well for transfected
Gβ1γ2, 95 ± 10 cpm per well for transfected
PLCβ2, and 1860 ± 350 cpm per well for
transfected PLCβ2 + Gβ1γ2. (c) The
specificity of the cRaf1 inhibition of Gβγ-
mediated PLCβ2 stimulation is shown by the
inability of cRaf1-CX(R89L,K375W) to inhibit
activation of PLCβ1 by Gαq or Gα11. The
increases in basal inositol phosphates were
3490 ± 320 cpm per well for transfected
PLCβ + Gαq and 6080 ± 720 cpm per well
for transfected PLCβ1 + Gα11. Basal inositol
phosphate levels of mock-transfected control
cells were 320 ± 40 cpm per well. Expression
of Gαq, Gα11, or PLCβ1 alone did not
significantly increase basal inositol phosphate
levels. Data are the means (± SEM) of three
or four different experiments.
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only the Gβγ-mediated component of the bradykinin
signal was blocked by activated cRaf1.
In contrast to the B2 receptor, PLCβ activation induced
by stimulation of the α2C adrenergic receptor with the
hormone medetomidine is inhibited only by cRaf1-CX
(see Supplementary material). The inhibition of the α2C
adrenergic receptor by cRaf1-CX is apparently more
complete than inhibition of the B2 receptor, probably
because the α2C adrenergic receptor is coupled to Gαi
and stimulation of PLC activity by the α2C receptor is an
effect mediated almost purely by the Gβγ-PLCβ2 inter-
action. Although the α2C adrenergic receptor is reported
to stimulate the MAP kinase pathway independently of
activation of Ras or Raf [13], in our hands, medetomidine
stimulation of transfected cells had no effect on cRaf1
kinase activity (see Supplementary material).
These results suggest that endogenous levels of cRaf1
affect the Gβγ component of bradykinin signalling.
Figure 4 shows that co-expression of dominant-negative
Ras, Ha-Ras(S17N), in B2-receptor-expressing cells
responding to bradykinin stimulation led to enhancement
of both inositol phosphate production and fluxes in intra-
cellular calcium. As Ha-Ras(S17N) inhibited the ability of
bradykinin to induce association of cRaf1 with the plasma
membrane of these cells (Figure 4d), the increased
responses that we observed indicate that endogenous
cRaf1 indeed limits the Gβγ component of bradykinin-
induced PLCβ activation.
Taken together, our data suggest an antagonistic regula-
tion of GPCRs by the MAP kinase cascade through inter-
action of cRaf1 with free Gβγ. Although this crosstalk is
independent of the catalytic activity of cRaf1, membrane
recruitment of the kinase seems essential. This phenome-
non is of particular interest in GPCR systems that activate
the MAP kinase cascade through the generation of GTP-
loaded Ras [14]. Our data reveal a feedback mechanism in
which the Gβγ signalling component of GPCRs is limited
by the membrane recruitment of cRaf1. As the binding
affinities of the Gβγ–cRaf1 and Gβγ–PLCβ2 complexes
are in the same range [6,15,16], it is possible that PLCβ2
and Ras-bound cRaf1 can compete for free Gβγ in the
membrane. Our data suggest that cRaf1, in addition to its
function in the MAP kinase cascade, has a role resembling
that of the protein phosducin, which, similar to cRaf1, is
expressed ubiquitously [17], inhibits Gβγ-mediated sig-
nalling pathways [18], and can be regulated [19]. In our
model, we propose downregulation of GPCR signals as a
consequence of the tightly controlled membrane recruit-
ment of Raf. This novel function of cRaf1 underlines the
notion that this kinase is an integral component of multi-
ple cellular pathways.
Supplementary material
Supplementary material including two supplementary figures and addi-
tional methodological details is available at http://current-
biology.com/supmat/supmatin.htm.
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Figure 3
Effect of cRaf1 on GPCR-stimulated increase of inositol phosphate
levels in bradykinin B2-receptor-transfected cells. (a) HEK293 or
COS-1 cells were transfected with a cDNA coding for the human B2
receptor and the levels of inositol phosphates compared with
bradykinin-stimulated cells was determined. The effect of cRaf1
expression on the increase in response to bradykinin (bradykinin + B2
receptor = 100%) was determined on cells cotransfected with cDNAs
encoding wild-type (wt) cRaf1, cRaf1-CX and cRaf1(R89L). The
inositol phosphate levels after stimulation with 1 × 10–7 M bradykinin of
cells transfected by the B2 receptor cDNA were 6890 ± 580 cpm per
well for COS-1 cells and 3840 ± 320 cpm per well for HEK293 cells.
Basal inositol phosphate levels were 670 ± 50 cpm per well and
320 ± 40 cpm per well for COS-1 and HEK293 cells, respectively.
Data are the means (± SEM) of three or four different experiments. 
(b) Assays for cRaf1 kinase activity of the immune complexes in (a)
following bradykinin stimulation. The substrate used to measure kinase
activity was a kinase-dead form of the kinase MEK (MEK(K97M)); the
band labelled ‘MEK(K97M)’ indicates 32PO43– incorporation into this
protein. Levels of cRaf1 expression, measured by western blotting, are
shown for comparison below.
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Effect of Ha-Ras(S17N) on B2-receptor-mediated signalling.
(a) HEK293 cells were transfected with the indicated cDNAs and
stimulated with 10 nM bradykinin (Bk) and the increase in inositol
phosphate levels was measured. (b,c) The rise in intracellular Ca2+
was then determined as described using cells (1 × 106) that had
incorporated Fura2 into their cytosols [22]. Data are representative of
three or four different experiments. (d) Western blot analysis showing
that Ha-Ras(S17N) inhibits bradykinin-induced association of
endogenous cRaf1 with the plasma membrane of B2-receptor-
transfected HEK293 cells. Cells transfected with B2 receptor with or
without Ha-Ras(S17N) were stimulated with 1 µM bradykinin for the
indicated times and the membrane fraction (P100) was isolated.
Protein concentration was equalised between the various samples
prior to separation by SDS–PAGE and western blotting with anti-
cRaf1 antibodies.
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Supplementary materials and methods
Materials
All HA-tagged cRaf1 proteins, including wild-type, R89L and K375W
mutants, a HA–cRaf1 modified at the carboxy terminus with the last 17
amino acids from Ki-Ras, including the CAAX sequence (HA–cRaf1-
CX), and Ha-Ras(G12V), Gβ1, Gγ2, α2C adrenergic receptor, bradykinin
B2 receptor and phospholipase Cβ2 were expressed from pcDNA3
(Invitrogen) vector constructs. The anti-HA monoclonal antibody was
purified from hybridoma (12CA5) cell lines (American Type Culture Col-
lection). Anti-cRaf1 rabbit polyclonal antibodies were generated and
characterised as described [S1]. Anti-Gβ antibodies were purchased
from Santa Cruz biotechnology. Protein-A–Sepharose was purchased
from Boehringer Mannheim. Enhanced chemoluminescence reagents,
film and [γ32P]ATP were purchased from Amersham Pharmacia.
Expression of proteins in insect (Spodoptera frugiderda)
SF9 cells
The cRaf1, lck, Ras(G12V), and Gβ1γ2 protein viral expression con-
structs were prepared as described [S2,S3]. Infection and harvest of
cells were performed using an established protocol [S4].
Mammalian cell transfections
COS-1 or HEK293 cells (American Type Culture Collection) were
grown in Dulbecco’s modified Eagle’s medium supplemented with
10% (v/v) FCS and kept in an atmosphere of 92.5% air and 7.5%
CO2. COS-1 cells were transfected using the DEAE–dextran method
with 12 µg DNA per 106 cells [S5], and HEK293 cells were trans-
fected by Ca2+ phosphate precipitation with 14 µg DNA/106 cells
[S6]. The transfection efficiency was usually 20–30% with COS-1
cells and 50–60% with HEK293 cells, as determined by staining of the
cells with X-Gal (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside)
after transfection with a plasmid encoding β-galactosidase [S5]. For
those experiments in which cells were used to determine inositol phos-
phate levels, cells were seeded on 12-well (COS-1) or 6-well
(HEK293) plates that were coated with 0.1% (w/v) gelatine in PBS.
Equal amounts of plasmids encoding the different proteins listed above
were used in cotransfection experiments, and the total amount of DNA
Supplementary material
Figure S1
Association of cRaf1 with Gβ1γ2 in HEK293 cells does not influence
cRaf1 protein kinase activity. HEK293 cells were transfected with the
indicated protein expression constructs (as in Figure 1) and lysed with
NP40 lysis buffer. The experiment shown is an immune-complex kinase
assay using the immunoprecipitated material (IP) from Figures 1a,b. The
substrate used to measure kinase activity was kinase-dead MEK(K97M),
and the illustrated band indicates incorporation of 32PO43– into this
protein. The data are representative of three experiments. Quantitative
analysis of 32PO43– incorporation into MEK(K97M) did not reveal any
significant increase in cRaf1 activity when cRaf1 or cRaf1-CX were
co-expressed with Gβ1γ2 (data not shown).
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Figure S2
Effect of cRaf1 on GPCR-stimulated increase of inositol phosphate
levels in α2C-adrenergic-receptor-transfected cells. (a) HEK293 cells
were transfected with a cDNA encoding the mouse α2C adrenergic
receptor and the levels of inositol phosphates compared with cells
stimulated with 1 × 10–6 M medetomidine was determined. The effect
of cRaf1 expression on the signal induced by medetomidine (100%)
was determined on cells cotransfected with cDNAs encoding the same
constructs of cRaf1 that were used with the B2 receptor (Figure 3).
The level of inositol phosphates in medetomidine-stimulated cells was
1050 ± 80 cpm per well. Data are the means (± SEM) of three different
experiments. (b) Kinase assays of the immune complexes in (a) to
detect cRaf1 activity following medetomidine stimulation.
– + – + – + – + – + – + – +Medetomidine
cRaf1
MEK(K97M)
cRaf1
expression
    
0
50
100
α2c receptor
HA–cRaf1(wt)
HA–cRaf-CX
HA–cRaf1(R89L)
In
os
ito
l p
ho
sp
ha
te
s 
(%
)
(a)
(b)
+ + + +
– – –
– –
–– –
–
+
+
+
HA
–c
Ra
f1
(w
t)
HA
–c
Ra
f1
-C
X
HA
–c
Ra
f1
(R
89
L)
α 2
c
 re
ce
pt
or
 +
 H
A–
cR
af1
(w
t)
α 2
c
 re
ce
pt
or
 +
 H
A–
cR
af1
-C
X
α 2
c
 re
ce
pt
or
 +
 H
A–
cR
af1
(R
89
L)
α 2
c
 re
ce
pt
or
Current Biology  
Phosphorylation
Blot: Anti-cRaf1
HEK293
was held constant using plasmid pcDNA3. For co-transfections with
Ha-Ras(G12V), 0.1 µg DNA per 106 cells was used.
Analysis of inositol phosphates
Transfected cells were serum-starved and then labelled with myo-[2-
3H]-inositol (2 µCi/ml, specific activity 17 Ci/mmol) for 24 h in inositol-
free RPMI medium containing 0.2% dialysed fetal calf serum (FCS).
Before the experiment, cells were washed with incubation buffer
(138 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1.5 mM CaCl2, 1 g/l glucose,
20 mM HEPES, pH 7.3), and stored for 5 min in incubation buffer sup-
plemented with 10 mM LiCl. The cells were then placed at 37°C, and
the experiment was started by the addition of buffer or hormone
(100 nM bradykinin or 1 µM medetomidine) to determine basal or
hormone-stimulated inositol phosphate levels, respectively. After 20 min,
total inositol phosphates were extracted as described previously [S7].
Analysis of membrane and cytosolic cellular compartments
Transfected cell pellets were resuspended in cold hypotonic lysis
buffer (25 mM NaF, 5 mM MgCl2, 2 mM EDTA, 2 mM EGTA, 1 mM
dithiothreitol, 10 mM Tris pH 7.5, 1 µg/ml leupeptin, 1 µg/ml aprotinin)
and lysis was performed by passing the resuspended cells through a
26 gauge needle 10 times. The lysed cells were then centrifuged at
1000 × g (30 min, 4°C), and the supernatant taken and further cen-
trifuged at 100,000 × g (60 min, 4°C) to obtain the cytosolic (S100)
and membrane (P100) fractions. The P100 fraction was washed once
with hypotonic lysis buffer, then solubilised with NP40 lysis buffer as
described. NP40 lysis buffer was also added to the S100 fraction to
assist immunoprecipitation. 
Kinase assays
Kinase assays were performed on isolated immune complexes by
washing the Sepharose beads with 1× kinase buffer (150 mM NaCl,
25 mM Na-glycerophosphate, 10 mM MgCl2, 25 mM HEPES pH 7.5),
and then resuspending the beads in 15 µl of 2× kinase buffer. Kinase-
dead MEK(K97M) was added with non-radioactive ATP (final concen-
tration 100 µM) and [γ32P]ATP (5 µCi per assay, specific activity
3,000 Ci/mmol). The total volume of the reaction mixture was 30 µl.
The mixture was incubated in a shaking 30°C water bath for 30 min
and then the reaction was stopped with 10 µl 4× SDS–PAGE sample
buffer and boiling (100°C, 5 min). The extent of MEK phosphorylation
was observed in proteins blotted on to nitrocellulose membranes using
either a phosphorimager (Fuji) or autoradiography.
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